Stephen T Oh (S Oh)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 55

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood cancer discovery 5 (3) (2024)
Duc Tran, J Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C C Chan, Zilan Xin, Michael H Kramer, Armel L Batchi-Bouyou, Xiaoyu Zong, Matthew J Walter, Giulia E M Petrone, Sarantis Chlamydas, Francesca Ferraro, Stephen T Oh, Daniel C Link, Ben Busby, Yin Cao, Kelly L Bolton
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Soriano Hobbs, Marina Kremyanskaya, Elliott F Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary J Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib: Final results. Blood advances (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Duc Tran, J Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C C Chan, Zilan Xin, Michael H Kramer, Armel L Batchi-Bouyou, Xiaoyu Zong, Matthew J Walter, Giulia E M Petrone, Sarantis Chlamydas, Francesca Ferraro, Stephen T Oh, Daniel C Link, Ben Busby, Yin Cao, Kelly L Bolton
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood cancer discovery 5 (3) (2024)
Homayemem Weli, John L Frater, Gail Shimer, Stephen T Oh, Cara Lunn Shirai
Pseudo-lymphocytosis caused by circulating megakaryocyte fragments in a patient with post-essential thrombocythemia myelofibrosis. International journal of laboratory hematology (2024)
Angelo B A Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood 143 (23) (2024)
Duc Tran, J Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C C Chan, Zilan Xin, Michael H Kramer, Armel L Batchi-Bouyou, Xiaoyu Zong, Matthew J Walter, Giulia E M Petrone, Sarantis Chlamydas, Francesca Ferraro, Stephen T Oh, Daniel C Link, Ben Busby, Yin Cao, Kelly L Bolton
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood cancer discovery 5 (3) (2024)
Angelo Brunelli Albertoni Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood (2024)
Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood cancer discovery (2024)
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan Carlos Carlos Hernández-Boluda, Prithviraj Bose, Konstanze Döhner, Martin Ellis, Naseema Gangat, Jacqueline S Garcia, Heinz Gisslinger, Jason Gotlib, Paola Guglielmelli, Vikas K Gupta, Claire N Harrison, Elizabeth O Hexner, Gabriela S Hobbs, Jean-Jacques Kiladjian, Steffen Koschmieder, Nicolaus M Kröger, Andrew T Kuykendall, Giuseppe Gaetano Loscocco, John O Mascarenhas, Lucia Masarova, Ruben A Mesa, Barbara Mora, Olatoyosi Odenike, Stephen T Oh, Animesh D Pardanani, Anand Ashwin Patel, Naveen Pemmaraju, Alessandro Rambaldi, Raajit K Rampal, Shireen Sirhan, Natasha Szuber, Moshe Talpaz, Pankit Vachhani, Alessandro M Vannucchi, Tiziano Barbui
Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis. Blood (2024)
Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow. Blood cancer discovery (2024)
Angelo Brunelli Albertoni Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood (2024)
Duc Tran, J Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C C Chan, Zilan Xin, Michael H Kramer, Armel L Batchi-Bouyou, Xiaoyu Zong, Matthew J Walter, Giulia E M Petrone, Sarantis Chlamydas, Francesca Ferraro, Stephen T Oh, Daniel C Link, Ben Busby, Yin Cao, Kelly L Bolton
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Angelo B A Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood 143 (23) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary Schiller, James McCloskey, Jeanne M Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval G Daver
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results. Blood advances 8 (6) (2024)
Angelo B A Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood 143 (23) (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Angelo B A Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher, Daniel T Starczynowski, Stephen T Oh
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms. Blood 143 (23) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
Peng Lu, Karolyn A Oetjen, Diane E Bender, Marianna B Ruzinova, Daniel A C Fisher, Kevin G Shim, Russell K Pachynski, W Nathaniel Brennen, Stephen T Oh, Daniel C Link, Daniel L J Thorek
IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry. Nature communications 14 (1) (2023)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
Peng Lu, Karolyn A Oetjen, Stephen T Oh, Daniel L J Thorek
Interpretable spatial cell learning enhances the characterization of patient tissue microenvironments with highly multiplexed imaging data. bioRxiv : the preprint server for biology (2023)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
J M O'Sullivan, J Taylor, Aaron T Gerds, S Buckley, C N Harrison, Stephen T Oh, A F List, Kieran Howard, H Dreau, A Hamblin, Adam J Mead
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort. Leukemia (2023)
Tim Kong, LaYow Yu, Angelo B A Laranjeira, Daniel A C Fisher, Fan He, Maggie J Cox, Stephen T Oh
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms. American journal of hematology (2023)
Stephen T Oh, Ruben A Mesa, Claire N Harrison, Prithviraj Bose, Aaron T Gerds, Vikas K Gupta, Bart L Scott, Jean-Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah A Buckley, Shanthakumar Tyavanagimatt, Bryan G Harder, Karisse Roman-Torres, Jennifer Smith, Adam R Craig, John O Mascarenhas, Srdan Verstovsek
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood advances (2023)
Srdan Verstovsek, Ruben A Mesa, Vikas K Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy Cirici, Stephen T Oh, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire N Harrison
Momelotinib Long-Term Safety and Survival in Myelofibrosis: Integrated Analysis of Phase 3 Randomized-Controlled Trials. Blood advances (2023)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
Michael D Iglesia, Reyka G Jayasinghe, Siqi Chen, Nadezhda V Terekhanova, John M Herndon, Erik Storrs, Alla Karpova, Daniel Cui Zhou, Nataly Naser Al Deen, Andrew T Shinkle, Rita Jui-Hsien Lu, Wagma Caravan, Andrew Houston, Yanyan Zhao, Kazuhito Sato, Preet Lal, Cherease Street, Fernanda Martins Rodrigues, Austin N Southard-Smith, André Luiz N Targino da Costa, Houxiang Zhu, Chia-Kuei Mo, Lisa Crowson, Robert S Fulton, Matthew A Wyczalkowski, Catrina C Fronick, Lucinda A Fulton, Hua Sun, Sherri R Davies, Elizabeth L Appelbaum, Sara E Chasnoff, Madelyn Carmody, Candace Brooks, Ruiyang Liu, Michael C Wendl, Clara Oh, Diane Bender, Cruchaga Carlos, Oscar Harari, Andrea Bredemeyer, Kory Lavine, Ron Bose, Julie Margenthaler, Jason M Held, Samuel Achilefu, Foluso Ademuyiwa, Rebecca Aft, Cynthia Ma, Graham A Colditz, Tao Ju, Stephen T Oh, James Fitzpatrick, E Shelley Hwang, Kooresh I Shoghi, Milan G Chheda, Deborah J Veis, Feng Chen, Ryan C Fields, William E Gillanders, Li Ding
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. bioRxiv : the preprint server for biology (2023)
Abdulraheem Yacoub, Ruben A Mesa, Stephen T Oh
Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib. JCO precision oncology 7 (2023)
Tim Kong, Angelo B A Laranjeira, Kangning Yang, Daniel A C Fisher, LaYow Yu, Laure Poittevin De La Frégonnière, Anthony Z Wang, Marianna B Ruzinova, Jared S Fowles, Mary C Fulbright, Maggie J Cox, Hamza Celik, Grant A Challen, Sidong Huang, Stephen T Oh
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. Nature cancer (2022)
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, Swati S Bhasin, William Pilcher, Deon Bryant Doxie, Edgar Gonzalez-Kozlova, Surendra Dasari, Mark A Fiala, Yered H Pita-Juárez, Michael Strausbauch, Geoffrey Kelly, Beena E Thomas, Shaji K Kumar, Hearn Jay Cho, Emilie Anderson, Michael C Wendl, Travis Dawson, Darwin D'souza, Stephen T Oh, Giulia Cheloni, Ying Li, John F DiPersio, Adeeb H Rahman, Kavita M Dhodapkar, Seunghee Kim-Schulze, Ravi Vij, Ioannis S Vlachos, Shaadi Mehr, Mark Hamilton, Daniel Auclair, Taxiarchis Kourelis, David Avigan, Madhav V Dhodapkar, Sacha Gnjatic, Manoj K Bhasin, Li Ding
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis. Cancer research communications 2 (10) (2022)
Tim Kong, Angelo B A Laranjeira, Kangning Yang, Daniel A C Fisher, LaYow Yu, Laure Poittevin De La Frégonnière, Anthony Z Wang, Marianna B Ruzinova, Jared S Fowles, Mary C Fulbright, Maggie J Cox, Hamza Celik, Grant A Challen, Sidong Huang, Stephen T Oh
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. Nature cancer 4 (1) (2022)
Ruben A Mesa, Claire Harrison, Stephen T Oh, Aaron T Gerds, Vikas K Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean-Jacques Kiladjian, Ewa Lech-Maranda, Donal P McLornan, Alessandro M Vannucchi, Uwe Platzbecker, Mei Huang, Bryan Strouse, Barbara J Klencke, Srdan Verstovsek
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis. Leukemia 36 (9) (2022)
Tim Kong, Angelo B A Laranjeira, Kangning Yang, Daniel A C Fisher, LaYow Yu, Laure Poittevin De La Frégonnière, Anthony Z Wang, Marianna B Ruzinova, Jared S Fowles, Mary C Fulbright, Maggie J Cox, Hamza Celik, Grant A Challen, Sidong Huang, Stephen T Oh
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. Nature cancer 4 (1) (2022)
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, Swati S Bhasin, William Pilcher, Deon Bryant Doxie, Edgar Gonzalez-Kozlova, Surendra Dasari, Mark A Fiala, Yered H Pita-Juárez, Michael Strausbauch, Geoffrey Kelly, Beena E Thomas, Shaji K Kumar, Hearn Jay Cho, Emilie Anderson, Michael C Wendl, Travis Dawson, Darwin D'souza, Stephen T Oh, Giulia Cheloni, Ying Li, John F DiPersio, Adeeb H Rahman, Kavita M Dhodapkar, Seunghee Kim-Schulze, Ravi Vij, Ioannis S Vlachos, Shaadi Mehr, Mark Hamilton, Daniel Auclair, Taxiarchis Kourelis, David Avigan, Madhav V Dhodapkar, Sacha Gnjatic, Manoj K Bhasin, Li Ding
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis. Cancer research communications 2 (10) (2022)
Tim Kong, Angelo B A Laranjeira, Kangning Yang, Daniel A C Fisher, LaYow Yu, Laure Poittevin De La Frégonnière, Anthony Z Wang, Marianna B Ruzinova, Jared S Fowles, Mary C Fulbright, Maggie J Cox, Hamza Celik, Grant A Challen, Sidong Huang, Stephen T Oh
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression. Nature cancer 4 (1) (2022)
Ruiyang Liu, Qingsong Gao, Steven M Foltz, Jared S Fowles, Lijun Yao, Julia Tianjiao Wang, Song Cao, Hua Sun, Michael C Wendl, Sunantha Sethuraman, Amila Weerasinghe, Michael P Rettig, Erik P Storrs, Christopher J Yoon, Matthew A Wyczalkowski, Joshua F McMichael, Daniel R Kohnen, Justin King, Scott R Goldsmith, Julie O'Neal, Robert S Fulton, Catrina C Fronick, Timothy J Ley, Reyka G Jayasinghe, Mark A Fiala, Stephen T Oh, John F Dipersio, Ravi Vij, Li Ding
Co-evolution of tumor and immune cells during progression of multiple myeloma. Nature communications 12 (1) (2021)
Hamza Celik, Ethan Krug, Christine R Zhang, Wentao Han, Nancy Issa, Won Kyun Koh, Hassan Bjeije, Ostap Kukhar, Maggie Allen, Tiandao Li, Daniel A C Fisher, Jared S Fowles, Terrence N Wong, Matthew C Stubbs, Holly K Koblish, Stephen T Oh, Grant A Challen
A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms. Cancer discovery (2021)
Tim Kong, Angelo Brunelli Albertoni Laranjeira, Taylor Collins, Elisa S De Togni, Abigail J Wong, Mary C Fulbright, Marianna B Ruzinova, Hamza Celik, Grant A Challen, Daniel A C Fisher, Stephen T Oh
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFkB pathway inhibition. Blood advances (2021)
Jason Gotlib, Andreas Reiter, Deepti H Radia, Michael W Deininger, Tracy I George, Jens Panse, Alessandro M Vannucchi, Uwe Platzbecker, Iván Alvarez-Twose, Andrzej Mital, Olivier Hermine, Ingunn Dybedal, Elizabeth O Hexner, Lisa K Hicks, Lambert Span, Ruben Mesa, Prithviraj Bose, Kristen M Pettit, Mark L Heaney, Stephen T Oh, Jayita Sen, Hui-Min Lin, Brenton G Mar, Daniel J DeAngelo
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nature medicine (2021)
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, Kim-Hien T Dao, Emily Stevens, Christopher A Eide, Vishesh Khanna, Angela Rofelty, Samantha Savage, Anna Reister Schultz, Nicola Long, Libbey White, Amy Carlos, Rachel Henson, Chenwei Lin, Robert Searles, Robert H Collins, Daniel J DeAngelo, Michael W Deininger, Tamara Dunn, Than Hein, Marlise R Luskin, Bruno C Medeiros, Stephen T Oh, Daniel A Pollyea, David P Steensma, Richard M Stone, Brian J Druker, Shannon K McWeeney, Julia E Maxson, Jason R Gotlib, Jeffrey W Tyner
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood 134 (11) (2019)
Jared S Fowles, Joan How, Maggie J Allen, Stephen T Oh
Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera. Leukemia 33 (6) (2019)
Daniel A C Fisher, Cathrine A Miner, Elizabeth K Engle, Hengrui Hu, Taylor B Collins, Amy Zhou, Maggie J Allen, Olga N Malkova, Stephen T Oh
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling. Leukemia 33 (8) (2019)